| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/09/2004 | US20040176316 Compounds for the normalization of the sleep/wake cycle |
| 09/09/2004 | US20040176312 Treatment of ungual and subungual diseases |
| 09/09/2004 | US20040176310 Use of extracts and preparations from iris plants and tectorigenin as medicaments |
| 09/09/2004 | US20040176309 Siglec inhibitors |
| 09/09/2004 | US20040176307 Method of regulating glucose metabolism, and reagents related thereto |
| 09/09/2004 | US20040176306 Compositions for raising uric acid levels and methods of using the same |
| 09/09/2004 | US20040176297 Characterizing and predicting responses; identifying most efficient, cost effective and/or convenient treatment regimens; computer profiling |
| 09/09/2004 | US20040176295 Method of promoting bone growth with hyaluronic acid and growth factors |
| 09/09/2004 | US20040176290 Anti-angiogenic state in mice and humans with retinal photorecptor cell degeneration |
| 09/09/2004 | US20040176289 Pharmaceutical composition for prevention and treatment of joint arthritis and a screening method thereof |
| 09/09/2004 | US20040176284 1,2-Dithio-5,8,11,14,17-pentaazocycloeicosane derivatives |
| 09/09/2004 | US20040176277 Methods of treating Pin1 associated disorders |
| 09/09/2004 | US20040176275 Pharmaceutical composition for alleviating tissue hypoxia and methods for alleviating tissue hypoxia |
| 09/09/2004 | US20040176274 Analgesic methods using endothelin receptor ligands |
| 09/09/2004 | US20040176272 Uses of integrin alphavbeta3 antagonists |
| 09/09/2004 | US20040176252 Well tolerated; intracellularly increasing cAMP; antiasthmatics, antiinflammatories: regulation of eosinophiles activation and degranulation |
| 09/09/2004 | US20040175774 Method for predicting the sensitivity to chemotherapy |
| 09/09/2004 | US20040175767 for lightening or darkening the pigmentation of cells and tissue (skin) in cells/cell-free systems; for drug screening |
| 09/09/2004 | US20040175766 Human pyrimidine receptor |
| 09/09/2004 | US20040175714 Human protooncogene kg-20 and protein encoded therein |
| 09/09/2004 | US20040175703 to be administered by inhalation, infusion, injection, or orally relates to double-stranded ribonucleic acid (dsRNA), and its use in mediating RNA interference in vitro and in vivo; genetic engineering |
| 09/09/2004 | US20040175700 Using phenotypic, genotypic, physiological and morphogenic variation profiles to diagnose and prognose genetic disorders; genomics |
| 09/09/2004 | US20040175448 Pharmaceutical compositions |
| 09/09/2004 | US20040175443 Food supplement for increasing lean mass and strength |
| 09/09/2004 | US20040175442 Food supplement for increasing lean mass and strength |
| 09/09/2004 | US20040175436 synthetic zeolites and selected herbal proteins (MPP) which is applied for prevention of the development of neuropathies in persons suffering diabetes; stops the process of apoptosis caused by accumulation of Ca2+ ions in cytplasm of nerve cells |
| 09/09/2004 | US20040175427 Omeprazole formulation |
| 09/09/2004 | US20040175426 in free-base or protonated acid form; for treating glaucoma; providing high concentrations of active compounds to the locus where their activity is desired |
| 09/09/2004 | US20040175424 Medicine based on anti-hyperglycaemic microcapsules with prolonged release and method for preparing same |
| 09/09/2004 | US20040175423 hydroxypropyl methyl cellulose is not part of the granule composition but is compressed with the granules into the final controlled release tablet |
| 09/09/2004 | US20040175422 excellent storage stability and little tendency to change the release rate of the pharmacologically active substance even after long-term storage; matrix comprising low-melting-point substance and pH-independent water-insoluble polymer |
| 09/09/2004 | US20040175421 improved glyburide dissolvability and bioavailability similar to single form dosage; glyburide in the form of fine dispersed particles with diameters of less than 45 mu m or, preferably, less than 35 mu m |
| 09/09/2004 | US20040175420 at least one non-ionic or zwitterionic surfactant and dispersant; improves the efficacy and/or potency of the lipase inhibitor; inter-subject variability in efficacy and/or potency is reduced, as well as the frequency and intensity of side effects |
| 09/09/2004 | US20040175419 controlling crystallization parameters of active ingredient to achieve increased compactability; compacting the active ingredient into a tablet |
| 09/09/2004 | US20040175418 Teste masking pharmaceutical composition |
| 09/09/2004 | US20040175415 Formulations and methods of delivery of intact tocopheryl succinate to humans |
| 09/09/2004 | US20040175411 Method of treating influenza |
| 09/09/2004 | US20040175410 Sustained release device and method for ocular delivery of carbonic anhydrase inhibitors |
| 09/09/2004 | US20040175402 Formulation |
| 09/09/2004 | US20040175401 Drug delivery to the dermis mammal to improve systemic absorption |
| 09/09/2004 | US20040175384 Protein kinase C as a target for the treatment of respiratory syncytial virus |
| 09/09/2004 | US20040175383 Administering to mammal a protease inhibitor comprising antitrypsin and/or ilomastat |
| 09/09/2004 | US20040175382 Methods of using and compositions comprising selective cytokine inhibitory drugs for the treatment and management of disorders of the central nervous system |
| 09/09/2004 | US20040175368 Use of crystal violet as photochemotherapeutic agent |
| 09/09/2004 | US20040175363 Defective recombinant adenovirus; treatment of neurodenerative, cardiovascular, brain, genetic, nervous system and respiratory system disorders; Alzheimer's, Parkinson's, amyotrophic lateral sclerosis (ALS), atherosclerosis, and/or trisomy 2; adult respiratory distress syndrome; anticarcinogenic agents |
| 09/09/2004 | US20040175353 Cyanoacrylate compositions for prophylactic or therapeutic treatment of diseases manifesting themselves in and/or damage cutaneous tissue |
| 09/09/2004 | US20040175352 Microbicidal compositions including an ionene polymer and 2,4,4-trichloro-2-hydroxydiphenyl ether, and methods of using the same |
| 09/09/2004 | US20040175349 Method of inhibiting hair growth |
| 09/09/2004 | US20040175348 formed by spray-drying a solution of an edible organic acid wherein chitosan is dissolved; storage stability |
| 09/09/2004 | US20040175346 Comprising cooling agent selected from the group consisting of l-menthol; menthyl lactate; menthone glycerine; etc. |
| 09/09/2004 | US20040175342 Process of making and using composition containing oxidation-sensitive hydrophilic active principle and maleic anhydride copolymer |
| 09/09/2004 | US20040175336 Prophylactic treatment of UV-induced epidermal neoplasia |
| 09/09/2004 | US20040173224 Nicotine salts having improved taste, process for their preparation and their use |
| 09/09/2004 | DE10308356A1 Cycloalkyl substituierte Alkansäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel Cycloalkyl substituted alkane acid derivatives, processes for their preparation and their use as medicaments |
| 09/09/2004 | DE10308352A1 Arylcycloalkylderivate mit verzweigten Seitenketten, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel Arylcycloalkylderivate with branched side chains, to processes for their preparation and their use as medicaments |
| 09/09/2004 | DE10308162A1 Verfahren zur Herstellung von Flavonoid-haltigen Zusammensetzungen und ihre Verwendung Process for the preparation of flavonoid-containing compositions and their use |
| 09/09/2004 | DE10307105A1 Antitumor wirksame 2-substituierte 18a-Homoestra-1,3,5(10)-trien-3-yl sulfamate Antitumor effective 2-substituted 18a-Homoestra-1,3,5 (10) -triene-3-yl sulfamates |
| 09/09/2004 | DE10307103A1 Antitumor wirksame 2-substituierte D-Homostra-1,3,5(10)-trien-3-yl sulfamate Antitumor effective 2-substituted D-Homostra-1,3,5 (10) -triene-3-yl sulfamates |
| 09/09/2004 | DE10107663B4 Testosteronhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung Testosterone-containing transdermal therapeutic system, process for its preparation and its use |
| 09/09/2004 | DE10004790B4 Method for producing sewn or embroidered three-dimensional textile structure utilized for e.g. table cloth, involves connecting points on lattice structure with threads to form thread arrangement under which lattice structure is not visible |
| 09/08/2004 | EP1455190A1 Modulation of the activity of nuclear receptors via EWS |
| 09/08/2004 | EP1455186A1 Screening method |
| 09/08/2004 | EP1454992A1 Anaplastic lymphoma kinase assay, reagents and compositions thereof |
| 09/08/2004 | EP1454990A1 Process for producing unsaturated fatty acid-containing oils |
| 09/08/2004 | EP1454984A1 Pharmaceutical compositions and their use, namely for the treatment of neurodegenerative diseases |
| 09/08/2004 | EP1454950A1 Pullulan-containing powder, process for producing the same and use thereof |
| 09/08/2004 | EP1454909A1 Substituted 8'-pyridinyl-dihydrospiro-(cycloalkyl)-pyrimido(1,2-a) pyrimidin-6-one and 8'-pyrimidinyl-dihydrospiro-(cycloalkyl)-pyrimido(1,2-a)pyrimidin-6-one derivatives and their use against neurodegenerative diseases |
| 09/08/2004 | EP1454907A1 Quninazoline and pyridopyrmidine derivatives |
| 09/08/2004 | EP1454903A1 Thiadiazoline derivative |
| 09/08/2004 | EP1454902A1 N- (substituted five-membered di-or triaza diunsaturated ring)carbonyl guanidine derivateives for the treatment of ischemia |
| 09/08/2004 | EP1454901A1 Piperazine compounds and pharmaceutical compositions containing them. |
| 09/08/2004 | EP1454898A1 Novel phenylalanine derivative |
| 09/08/2004 | EP1454893A1 Illudin analogs useful as antitumor agents |
| 09/08/2004 | EP1454890A2 Anti-tumor Acylfulvenes |
| 09/08/2004 | EP1454636A1 Sterilization of glucocorticoid drug particles for pulmonary delivery |
| 09/08/2004 | EP1454634A1 Preparation compositions containing acid-unstable physiologically acitve compounds and process for producing the same |
| 09/08/2004 | EP1454633A1 Cosmetic or pharmaceutical composition for topical use to prevent or treat androgenetic alopecia |
| 09/08/2004 | EP1454626A1 Method of inducing apoptosis and compositions therefor |
| 09/08/2004 | EP1454625A1 Pyridylsulfonamidyl-pyrimidines for the treatment of diabetic nephropathies |
| 09/08/2004 | EP1454624A1 Antiviral, antibacterial pharmaceutical composition of cantharidic anhydride and method of preparation thereof |
| 09/08/2004 | EP1454618A1 Anticaries compositions containing phaseolamin |
| 09/08/2004 | EP1454610A1 Cosmetic and/or pharmaceutical compositions comprising microencapsulated plant extracts |
| 09/08/2004 | EP1454533A1 Stimulation of saliva generation |
| 09/08/2004 | EP1454142A2 Inhibition of tristetraproline for protection of the heart from cardiac injuries |
| 09/08/2004 | EP1454140A2 Diagnosis and treatment of atherosclerosis |
| 09/08/2004 | EP1453962A2 Inhibitor oligonucleotides and their use for specific repression of a gene |
| 09/08/2004 | EP1453916A2 Novel combination containing a poloxamer and chondroitin sulphuric acid and/or a glycoprotein and use thereof |
| 09/08/2004 | EP1453913A2 Novel substituted alkane compounds and uses thereof |
| 09/08/2004 | EP1453856A1 Beta-amyloid binding factors and inhibitors thereof |
| 09/08/2004 | EP1453854A2 Human cdnas and proteins and uses thereof |
| 09/08/2004 | EP1453852A2 Selective urokinase inhibitors |
| 09/08/2004 | EP1453849A2 Antisense modulation of purinoreceptor p2x3 |
| 09/08/2004 | EP1453847A1 6-o-acyl ketolide derivatives of erythromycine useful as antibacterials |
| 09/08/2004 | EP1453846A1 Macrolides |
| 09/08/2004 | EP1453845A2 Compositions of nucleic acids and cationic aminoglycosides and methods of using and preparing the same |
| 09/08/2004 | EP1453844A2 Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents |
| 09/08/2004 | EP1453841A1 Technetium or rhenium complexes, radiopharmaceutical products comprising them |
| 09/08/2004 | EP1453840A1 Phosphonates useful as modulators of t-gamma-9-delta-2 lymphocyte activity |
| 09/08/2004 | EP1453837A2 Targeted therapeutics and uses thereof |
| 09/08/2004 | EP1453836A1 1,2,4]-TRIAZOLE BICYCLIC ADENOSINE A 2a RECEPTOR ANTAGONISTS |